11/18
08:22 am
bhc
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis [Yahoo! Finance]
Low
Report
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis [Yahoo! Finance]
11/18
08:22 am
bhc
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS [Yahoo! Finance]
Low
Report
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS [Yahoo! Finance]
11/18
08:00 am
bhc
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
Low
Report
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
11/18
08:00 am
bhc
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Low
Report
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
11/14
02:08 pm
bhc
Photodynamic Therapy Market to Grow by USD 2.35 Billion (2024-2028), Driven by Rising Cancer Prevalence, AI-Powered Report Highlights Market Trends - Technavio [Yahoo! Finance]
Low
Report
Photodynamic Therapy Market to Grow by USD 2.35 Billion (2024-2028), Driven by Rising Cancer Prevalence, AI-Powered Report Highlights Market Trends - Technavio [Yahoo! Finance]
11/6
11:24 am
bhc
Are Medical Stocks Lagging Bausch Health (BHC) This Year? [Yahoo! Finance]
Low
Report
Are Medical Stocks Lagging Bausch Health (BHC) This Year? [Yahoo! Finance]
11/6
06:42 am
bhc
Indonesia Medical Aesthetics Market Report 2024-2029 - 11.5% CAGR Forecast, with Market Set to Reach USD 495.64 Million by 2029 [Yahoo! Finance]
Medium
Report
Indonesia Medical Aesthetics Market Report 2024-2029 - 11.5% CAGR Forecast, with Market Set to Reach USD 495.64 Million by 2029 [Yahoo! Finance]
11/5
01:13 pm
bhc
At 11.1% CAGR Aesthetic Medical Devices Market Size to Reach $44.60 Billion By 2031 | The Insight Partners [Yahoo! Finance]
Low
Report
At 11.1% CAGR Aesthetic Medical Devices Market Size to Reach $44.60 Billion By 2031 | The Insight Partners [Yahoo! Finance]
11/5
04:18 am
bhc
Renal Cell Carcinoma (RCC) Industry Report 2024-2032: U.S. and EU-4 Lead the Global Renal Cell Carcinoma Market, Driven by Healthcare Infrastructure, Aging Populations, and Innovation from Key Pharma Leaders [Yahoo! Finance]
Medium
Report
Renal Cell Carcinoma (RCC) Industry Report 2024-2032: U.S. and EU-4 Lead the Global Renal Cell Carcinoma Market, Driven by Healthcare Infrastructure, Aging Populations, and Innovation from Key Pharma Leaders [Yahoo! Finance]
11/4
11:43 am
bhc
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
Medium
Report
Why Bausch Health (BHC) is a Top Momentum Stock for the Long-Term [Yahoo! Finance]
11/1
11:27 am
bhc
Bausch Health Companies Inc. (NYSE: BHC) had its price target raised by analysts at Royal Bank of Canada from $10.00 to $11.00. They now have a "sector perform" rating on the stock.
Low
Report
Bausch Health Companies Inc. (NYSE: BHC) had its price target raised by analysts at Royal Bank of Canada from $10.00 to $11.00. They now have a "sector perform" rating on the stock.
10/30
04:05 pm
bhc
Bausch Health Announces Third Quarter 2024 Results
High
Report
Bausch Health Announces Third Quarter 2024 Results
10/30
05:11 am
bhc
Skincare Devices - Strategic Business and Industry Analysis Report 2024-2030 - Emergence of Smart and AI-Enabled Skincare Devices Creates New Opportunities for Market Innovation [Yahoo! Finance]
Low
Report
Skincare Devices - Strategic Business and Industry Analysis Report 2024-2030 - Emergence of Smart and AI-Enabled Skincare Devices Creates New Opportunities for Market Innovation [Yahoo! Finance]
10/27
12:15 pm
bhc
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Low
Report
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
10/25
02:07 am
bhc
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Medium
Report
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
10/24
07:44 am
bhc
South Korea Medical Aesthetics Market Report 2024-2029: Growing Role of Medical Tourism, Popularity of Male Aesthetics, Injectables to Influence Future Growth Prospects [Yahoo! Finance]
Low
Report
South Korea Medical Aesthetics Market Report 2024-2029: Growing Role of Medical Tourism, Popularity of Male Aesthetics, Injectables to Influence Future Growth Prospects [Yahoo! Finance]
10/23
11:14 am
bhc
Bausch Health (BHC) Reports Next Week: What to Expect [Yahoo! Finance]
Low
Report
Bausch Health (BHC) Reports Next Week: What to Expect [Yahoo! Finance]
10/23
10:52 am
bhc
2024 Research | Europe Retinal Surgery Devices Market Poised for Growth, Expected to Reach $1.16 Billion by 2032, Driven by Rising Prevalence of Retinal Diseases and Technological Advancements [Yahoo! Finance]
Low
Report
2024 Research | Europe Retinal Surgery Devices Market Poised for Growth, Expected to Reach $1.16 Billion by 2032, Driven by Rising Prevalence of Retinal Diseases and Technological Advancements [Yahoo! Finance]
10/19
08:44 am
bhc
Investors in Common Stock and Certain Debt Securities Offered by Valeant Pharmaceuticals International, Inc. May be Entitled to Payment from an SEC Fair Fund [Globe and Mail, The (Toronto, Canada)]
Low
Report
Investors in Common Stock and Certain Debt Securities Offered by Valeant Pharmaceuticals International, Inc. May be Entitled to Payment from an SEC Fair Fund [Globe and Mail, The (Toronto, Canada)]
10/17
11:10 pm
bhc
Bausch Health Companies Inc. (NYSE: BHC) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Low
Report
Bausch Health Companies Inc. (NYSE: BHC) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
10/17
07:28 am
bhc
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at Evercore ISI to a "hold" rating.
Low
Report
Bausch Health Companies Inc. (NYSE: BHC) was upgraded by analysts at Evercore ISI to a "hold" rating.
10/14
05:13 pm
bhc
Ophthalmology Devices Market projected to grow by USD 19.1 Billion from 2024-2028, driven by AI-powered innovations and rising prevalence of ophthalmic diseases - Technavio [Yahoo! Finance]
Low
Report
Ophthalmology Devices Market projected to grow by USD 19.1 Billion from 2024-2028, driven by AI-powered innovations and rising prevalence of ophthalmic diseases - Technavio [Yahoo! Finance]
10/13
09:15 am
bhc
Bausch Health Companies (NYSE:BHC shareholders incur further losses as stock declines 4.4% this week, taking three-year losses to 72% [Yahoo! Finance]
Medium
Report
Bausch Health Companies (NYSE:BHC shareholders incur further losses as stock declines 4.4% this week, taking three-year losses to 72% [Yahoo! Finance]
10/10
06:19 am
bhc
Body Contouring Devices Focused Insights Report 2024-2029: AbbVie, Bausch Health, Cutera, Shanghai Fosun Pharmaceutical, and Hologic Load the $15+ Billion Body Contouring Devices Market [Yahoo! Finance]
Medium
Report
Body Contouring Devices Focused Insights Report 2024-2029: AbbVie, Bausch Health, Cutera, Shanghai Fosun Pharmaceutical, and Hologic Load the $15+ Billion Body Contouring Devices Market [Yahoo! Finance]
10/9
04:05 pm
bhc
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
Low
Report
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024